• 1
    Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30: 735742.
  • 2
    Verleden GM, Vos R, Verleden SE, et al. Survival determinants in lung transplant patients with chronic allograft dysfunction. Transplantation 2011; 92: 703708.
  • 3
    Sato M, Hwang DM, Waddell TK, Singer LG, Keshavjee S. Progression pattern of restrictive allograft syndrome after lung transplantation. J Heart Lung Transplant 2013; 32: 2330.
  • 4
    Ofek E, Sato M, Saito T, et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol 2013; 26: 350356.
  • 5
    Verleden SE, Ruttens D, Vandermeulen E, et al. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: Do risk factors differ? Transplantation 2013; 95: 11671172.
  • 6
    Sivakumar P, Ntolios P, Jenkins G, Laurent G. Into the matrix: Targeting fibroblasts in pulmonary fibrosis. Curr Opin Pulm Med 2012; 18: 462469.
  • 7
    Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials. Lancet 2011; 377: 17601769.
  • 8
    Bizargity P, Liu K, Wang L, Hancock WW, Visner GA. Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection. Transplantation 2012; 94: 114122.
  • 9
    Ihle F, von Wulffen Werner, Neurorh C. Pirfenidone: A potential therapy for progressive lung allograft dysfunction? J Heart Lung Transplant 2013; 32: 574575.
  • 10
    Kohno M, Perch M, Andersen E, Carlsen J, Andersen CB, Iversen M. Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation. Transplant Proc 2011; 43: 18681870.
  • 11
    de Jong PA, Vos R, Verleden GM, Vanaudenaerde BM, Verschakelen JA. Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction. Eur Radiol 2011; 21: 24662474.
  • 12
    Win T, Lambrou T, Hutton BF, et al. 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: Implications for future clinical trials. Eur J Nucl Med Mol Imaging 2012; 39: 521528.